Clinical Trial Update: TRIAD - Tracking Risk in Integrated Alzheimer's Diagnostics.

View source ↗

Summary

The TRIAD study (Tracking Risk in Integrated Alzheimer's Diagnostics) is currently recruiting to evaluate integrated diagnostics for cognitive decline related t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Istituti Clinici Scientifici Maugeri SpA | Conditions: Cognitive Decline | Status: RECRUITING